Fundraising FoxSenesTech
NASDAQ: SNESPhoenix, US · Founded 2015 · Delaware corporation
Find your way into SenesTech
Sign up to see every warm intro you have to SenesTech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SenesTech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SenesTech develops fertility-control products for managing rodent populations, offering an alternative to traditional rodenticides. Its approach targets pest control through reproduction limitation rather than lethal poisons.
Founders & leadership
TC
Thomas C. ChestermanExecutiveThomas C. Chesterman is Executive Officer of SenesTech, which develops fertility-control products for managing rodent populations. He brings over 25 years of executive leadership across multiple industries, with experience in operations, contract negotiation, acquisitions, and strategic planning in both startup and large-corporation settings.
JL
Joel L. FruendtChief Executive OfficerJoel L. Fruendt serves as Chief Executive Officer of SenesTech, which develops fertility-control products for rodent population management. He has over twenty years of executive experience in operations, business strategy, and scaling organizations across various industries.
KS
Kenneth SiegelChief Executive Officer and Director
ME
Michael EdellInterim Chief Operating Officer
JW
Julie Williams, MDNamed on SEC filing
MD
Marc DumontNamed on SEC filing
DF
Delphine Francois ChiavariniNamed on SEC filing
Board
MK
Matthew K. SzotBoard director
PG
Phillip Grandinetti, IIIBoard director
JL
Jake LeachBoard director
JB
Jamie Bechtel, JD, Ph.D.Board director
Reported raises · per SEC filings
Form D private placements$17.2M disclosed across 7 of 10 rounds · 2020–2025
▶$273.5KraisedAug 2025 · 5 investors · OtherRule 506(b)
▶$273.5KraisedAug 2025 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Joel L. FruendtExecutive Officer, Director
- Jake S. LeachDirector
- Jamie Bechtel, JD, Ph.D.Director
- Phillip N. Grandinetti, IIIDirector
- Thomas C. ChestermanExecutive Officer
- Offering amount
- $273.5K
- Amount sold
- $273.5K
- Sales commissions
- $474.6K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$182.4KraisedJul 2025 · 5 investors · OtherRule 506(b)
▶$182.4KraisedJul 2025 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Joel L. FruendtExecutive Officer, Director
- Jamie Bechtel, JD, Ph.D.Director
- Phillip N. Grandinetti, IIIDirector
- Thomas C. ChestermanExecutive Officer
- Jake S. LeachDirector
- Offering amount
- $182.4K
- Amount sold
- $182.4K
- Sales commissions
- $331K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedMar 2025 · 5 investors · AgricultureRule 506(b)
▶Undisclosed amountofferedMar 2025 · 5 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Thomas C. ChestermanExecutive Officer
- Phillip Grandinetti, IIIDirector
- Joel FruendtExecutive Officer
- Jake LeachDirector
- Jamie Bechtel, JD, Ph.D.Director
- Matthew K. SzotDirector
- Joshua M. MossDirector
- Sales commissions
- $81.5K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedAug 2024 · 6 investors · AgricultureRule 506(b)
▶Undisclosed amountofferedAug 2024 · 6 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Matthew K. SzotDirector
- Phillip Grandinetti, IIIDirector
- Jake LeachDirector
- Thomas C. ChestermanExecutive Officer
- Joel L. FruendtExecutive Officer, Director
- Jamie Bechtel, JD, Ph.D.Director
- Sales commissions
- $174.4K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedSep 2023 · 1 investors · AgricultureRule 506(b)
▶Undisclosed amountofferedSep 2023 · 1 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Joel L. FruendtExecutive Officer, Director
- Jamie Bechtel, JD, Ph.D.Director
- Thomas C. ChestermanExecutive Officer
- Delphine Francois ChiavariniDirector
- Phillip Grandinetti, IIIDirector
- Jake LeachDirector
- Matthew K. SzotDirector
- Sales commissions
- $158.5K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedApr 2023 · 4 investors · AgricultureRule 506(b)
▶$1.5MraisedApr 2023 · 4 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Matthew K. SzotDirector
- Jamie Bechtel, JD, Ph.D.Director
- Delphine Francois ChiavariniDirector
- Thomas C. ChestermanExecutive Officer
- Joel L. FruendtExecutive Officer, Director
- Marc DumontDirector
- Phil Grandinetti, IIIDirector
- Nicole WilliamsExecutive Officer, Director
- Jake LeachDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Sales commissions
- $112.5K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedFeb 2021 · 19 investors · BiotechnologyRule 506(b)
▶$10MraisedFeb 2021 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jamie Bechtel, JD, Ph.D.Director
- Delphine ChiavariniDirector
- Marc DumontDirector
- Matthew SzotDirector
- Phil Grandinetti, IIIDirector
- K.C. KavanaghDirector
- Steven Krause, Ph.D.Executive Officer
- Kim WolinExecutive Officer
- Thomas C ChestermanExecutive Officer
- Kenneth SiegelExecutive Officer, Director
- Jake LeachDirector
- Offering amount
- $10M
- Amount sold
- $10M
- Sales commissions
- $850K
- Placement agents
- H.C. Wainwright & Co.
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.1MraisedNov 2020 · 5 investors · BiotechnologyRule 506(b)
▶$3.1MraisedNov 2020 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Julie Williams, MDDirector
- Matthew SzotDirector
- Marc DumontDirector
- Delphine Francois ChiavariniDirector
- Kenneth SiegelExecutive Officer, Director
- Thomas C ChestermanExecutive Officer
- Jamie Bechtel, JD, Ph.D.Director
- Offering amount
- $3.1M
- Amount sold
- $3.1M
- Sales commissions
- $220K
- Finders' fees
- $29.3K
- Placement agents
- H.C. Wainwright & Co.
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2011 | $844.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $100K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does SenesTech do?
- SenesTech develops fertility-control products for managing rodent populations, offering an alternative to traditional rodenticides. Its approach targets pest control through reproduction limitation rather than lethal poisons.
- How much funding has SenesTech raised?
- SenesTech has disclosed $17.2M raised across 7 of its 10 known rounds.
- Where is SenesTech headquartered?
- SenesTech is headquartered in Phoenix, US.